PL1988891T3 - Kompozycje oraz sposoby wywoływania wzrostu kości i hamowania zanikania kości - Google Patents

Kompozycje oraz sposoby wywoływania wzrostu kości i hamowania zanikania kości

Info

Publication number
PL1988891T3
PL1988891T3 PL07751503T PL07751503T PL1988891T3 PL 1988891 T3 PL1988891 T3 PL 1988891T3 PL 07751503 T PL07751503 T PL 07751503T PL 07751503 T PL07751503 T PL 07751503T PL 1988891 T3 PL1988891 T3 PL 1988891T3
Authority
PL
Poland
Prior art keywords
compositions
methods
inducing
inhibiting
bone
Prior art date
Application number
PL07751503T
Other languages
English (en)
Inventor
Yuanlong Pan
Original Assignee
Nestec S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec S.A. filed Critical Nestec S.A.
Publication of PL1988891T3 publication Critical patent/PL1988891T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pyrane Compounds (AREA)
PL07751503T 2006-02-28 2007-02-22 Kompozycje oraz sposoby wywoływania wzrostu kości i hamowania zanikania kości PL1988891T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77766606P 2006-02-28 2006-02-28

Publications (1)

Publication Number Publication Date
PL1988891T3 true PL1988891T3 (pl) 2017-05-31

Family

ID=38459575

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07751503T PL1988891T3 (pl) 2006-02-28 2007-02-22 Kompozycje oraz sposoby wywoływania wzrostu kości i hamowania zanikania kości

Country Status (12)

Country Link
US (2) US8242100B2 (pl)
EP (1) EP1988891B1 (pl)
JP (1) JP5227195B2 (pl)
CN (1) CN101389328B (pl)
BR (1) BRPI0708361A2 (pl)
CA (1) CA2640575C (pl)
ES (1) ES2604656T3 (pl)
HU (1) HUE032901T2 (pl)
PL (1) PL1988891T3 (pl)
RU (1) RU2403036C2 (pl)
WO (1) WO2007100671A2 (pl)
ZA (1) ZA200808245B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1933739A (zh) * 2004-03-17 2007-03-21 雀巢技术公司 减少或预防肥胖的组合物和方法
EP2133080A1 (de) * 2008-06-13 2009-12-16 Haelan Schweiz GmbH Zusammensetzungen enthaltend Equol
US8835490B2 (en) * 2008-08-15 2014-09-16 Nestec Sa Methods for enhancing energy metabolism
WO2011084886A1 (en) * 2010-01-06 2011-07-14 Nestec S. A. Dietary regimens useful for mimicking caloric restriction
EP2898923A3 (en) * 2011-04-15 2015-10-07 Nestec S.A. Isoflavones for regulating sirtuin gene expression
US11576404B2 (en) 2016-11-30 2023-02-14 Purina Animal Nutrition Llc Isoflavone-supplemented milk replacers and systems and methods of feeding same to young animals
US11758928B2 (en) 2016-12-15 2023-09-19 Société des Produits Nestlé S.A. Compositions and methods that modulate phosphorus or enzymes in a companion animal
US11617737B2 (en) 2016-12-15 2023-04-04 Société des Produits Nestlé S.A. Compositions and methods that modulate vitamin D and bone mineral content in a companion animal
WO2018118196A1 (en) * 2016-12-21 2018-06-28 Richard Postrel Healthier aging in domesticated animals
US20190166884A1 (en) * 2017-12-06 2019-06-06 Purina Animal Nutrition Llc Isoflavone-Supplemented Chick Diets and Methods of Feeding the Same
US20230165281A1 (en) * 2021-11-29 2023-06-01 Société des Produits Nestlé S.A. Methods and compositions for providing a health benefit in an animal
EP4580419A1 (en) * 2022-09-01 2025-07-09 Barlaa B.V. Silicic acid for improving milk production in dairy livestock

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3009599B2 (ja) * 1995-02-24 2000-02-14 フジッコ株式会社 フラボノイド配糖体を含む骨粗鬆症治療剤および骨粗鬆症治療用の可食性組成物
JP2003183166A (ja) * 1996-03-21 2003-07-03 Fujicco Co Ltd イソフラボン誘導体の苦味，渋味，収斂味の抑制剤、当該抑制剤を用いた苦味，渋味，収斂味の抑制方法、及びイソフラボン誘導体を含有する可食物
WO1999065337A1 (en) * 1998-06-19 1999-12-23 Beth Israel Deaconess Medical Center Dietary supplement for post-menopausal women
IT1299191B1 (it) * 1998-06-23 2000-02-29 Sigma Tau Healthscience Spa Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
AUPQ008399A0 (en) * 1999-04-28 1999-05-27 Novogen Research Pty Ltd Cariovascular applications
WO2001087315A1 (en) 2000-05-12 2001-11-22 Anadis Limited Treatment or prevention of metabolic bone disorder
JP2002058452A (ja) * 2000-08-14 2002-02-26 Masahiko Nishimura 骨密度改善機能を有するカルシウム含有食品組成物
JP2004515508A (ja) * 2000-12-16 2004-05-27 アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 化合物の健康促進組成物
DE10204634A1 (de) 2001-02-05 2002-10-31 Greither Salus Haus Dr Otto Sojaisoflavonhaltiges Produkt für Männer
AUPR363301A0 (en) 2001-03-08 2001-04-05 Novogen Research Pty Ltd Dimeric isoflavones
ES2289097T3 (es) * 2001-03-15 2008-02-01 Dsm Ip Assets B.V. Composicion para la prevencion de la osteoporosis consistente de una combinacion de isoflavonas y acidos grasos poliinsaturados.
CN104643057A (zh) * 2002-07-24 2015-05-27 儿童医院医疗中心 含有对映体牛尿酚的组合物和产物及其用途
US20040071685A1 (en) 2002-10-09 2004-04-15 Devin Houston Compositions and methods for increasing the bioavailability of plant polyphenols
CN1933739A (zh) * 2004-03-17 2007-03-21 雀巢技术公司 减少或预防肥胖的组合物和方法

Also Published As

Publication number Publication date
WO2007100671A3 (en) 2008-04-24
CN101389328A (zh) 2009-03-18
CA2640575C (en) 2016-05-17
EP1988891A4 (en) 2011-06-22
RU2008138558A (ru) 2010-04-10
BRPI0708361A2 (pt) 2011-05-24
US8242100B2 (en) 2012-08-14
WO2007100671A2 (en) 2007-09-07
JP2009533319A (ja) 2009-09-17
AU2007221221A1 (en) 2007-09-07
ZA200808245B (en) 2009-12-30
US20120277300A1 (en) 2012-11-01
EP1988891A2 (en) 2008-11-12
ES2604656T3 (es) 2017-03-08
HUE032901T2 (hu) 2017-11-28
CA2640575A1 (en) 2007-09-07
US20090054386A1 (en) 2009-02-26
RU2403036C2 (ru) 2010-11-10
JP5227195B2 (ja) 2013-07-03
US8518921B2 (en) 2013-08-27
CN101389328B (zh) 2013-04-24
EP1988891B1 (en) 2016-10-26

Similar Documents

Publication Publication Date Title
ZA200808245B (en) Compositions and methods for inducing bone growth and inhibiting bone loss
AP2885A (en) Methods and compositions for improving plant health
IL195619A0 (en) Compositions and methods for joininig non-conjoined iumens
IL198684A0 (en) Compositions and methods for bone formation and remodeling
GB0620400D0 (en) Spinal implant
ZA201001810B (en) Seed treatment compositions and methods
ZA201001811B (en) Seed treatment compositions and methods
PT2101766T (pt) Composições e métodos de utilização de (r)-pramipexole
ZA200906390B (en) Compositions and methods for promoting bone development
IL194387A0 (en) Methods and compositions for vaccination of poultry
PT2101676E (pt) Disposição para a inserção de implantes
IL196465A0 (en) Compositions and methods for the treatment of mucositis
IL198649A0 (en) Interspinous implant
IL198310A0 (en) Compositions and method for hair loss prevention
ZA200801424B (en) Synergistic compostion and method for inhibiting growth of microorganisms
PL2101766T3 (pl) Kompozycje i sposoby stosowania (R)-pramipeksolu
IL205248A0 (en) Compositions and methods for making androstenediones
GB0718918D0 (en) Compositions and methods for treating skin conditions
GB0605247D0 (en) Compositions and methods for immunisation
IL196638A0 (en) Methods and compositions for treating disease
EP1963485A4 (en) METHOD AND COMPOSITIONS FOR IMPROVING PLANT GROWTH
EP2094279A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF INFLUENZA
GB0411153D0 (en) Compositions and methods for inhibiting bone resorption
PL379885A1 (pl) Implanto-dystraktor stomatologiczny
PL379475A1 (pl) Implanto-dystraktor stomatologiczny